452 related articles for article (PubMed ID: 19701735)
41. JC polyomavirus nephropathy, a rare cause of transplant dysfunction: Case report and review of literature.
Yang D; Keys B; J Conti D; Foulke L; Stellrecht K; Cook L; Lopez-Soler RI
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28036142
[TBL] [Abstract][Full Text] [Related]
42. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis.
Poduval RD; Meehan SM; Woodle ES; Thistlethwaite JR; Haas M; Cronin DC; Vats A; Josephson MA
Transplantation; 2002 Apr; 73(7):1166-9. PubMed ID: 11965053
[TBL] [Abstract][Full Text] [Related]
43. BKV reactivation in renal transplant recipients: diagnostic and therapeutic strategy--case reports.
Sessa A; Esposito A; Giliberti A; Bergallo M; Costa C; Rossano R; Lettieri E; Capuano M
Transplant Proc; 2008; 40(6):2055-8. PubMed ID: 18675128
[TBL] [Abstract][Full Text] [Related]
44. High-Dose Intravenous Immunoglobulin Treatment of Polyomavirus Nephropathy Developing After T Cell-Mediated Rejection Treatment: A Case Report.
Hwang SD; Lee JH; Lee SW; Kim JK; Kim MJ; Song JH
Transplant Proc; 2018 Oct; 50(8):2575-2578. PubMed ID: 29871774
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of mTOR Inhibitors and Intravenous Immunoglobulin for Treatment of Polyoma BK Nephropathy in Kidney Transplant Recipients: A Biopsy-Proven Study.
Karatas M; Tatar E; Okut G; Yildirim AM; Kocabas E; Tasli Alkan F; Simsek C; Dogan SM; Uslu A
Exp Clin Transplant; 2024 Jan; 22(Suppl 1):118-127. PubMed ID: 38385385
[TBL] [Abstract][Full Text] [Related]
46. Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy.
Barri YM; Ahmad I; Ketel BL; Barone GW; Walker PD; Bonsib SM; Abul-Ezz SR
Clin Transplant; 2001 Aug; 15(4):240-6. PubMed ID: 11683817
[TBL] [Abstract][Full Text] [Related]
47. Polyomavirus nephropathy: morphology, pathophysiology, and clinical management.
Nickeleit V; Singh HK; Mihatsch MJ
Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):599-605. PubMed ID: 14564196
[TBL] [Abstract][Full Text] [Related]
48. Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection.
Teschner S; Gerke P; Geyer M; Wilpert J; Krumme B; Benzing T; Walz G
Transplant Proc; 2009; 41(6):2533-8. PubMed ID: 19715969
[TBL] [Abstract][Full Text] [Related]
49. BK virus-associated nephropathy in a lung transplant patient: case report and literature review.
Crowhurst T; Nolan J; Faull R; Holmes M; Holmes-Liew CL
BMC Infect Dis; 2020 Aug; 20(1):600. PubMed ID: 32795251
[TBL] [Abstract][Full Text] [Related]
50. Impact of combined acute rejection on BK virus-associated nephropathy in kidney transplantation.
Kim YJ; Jeong JC; Koo TY; Kwon HY; Han M; Jeon HJ; Ahn C; Yang J
J Korean Med Sci; 2013 Dec; 28(12):1711-5. PubMed ID: 24339698
[TBL] [Abstract][Full Text] [Related]
51. BK virus infection in kidney transplant recipients.
Kim HC; Hwang EA; Kang MJ; Han SY; Park SB; Park KK
Transplant Proc; 2004 Sep; 36(7):2113-5. PubMed ID: 15518765
[TBL] [Abstract][Full Text] [Related]
52. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy.
Saad ER; Bresnahan BA; Cohen EP; Lu N; Orentas RJ; Vasudev B; Hariharan S
Transplantation; 2008 Mar; 85(6):850-4. PubMed ID: 18360267
[TBL] [Abstract][Full Text] [Related]
53. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
[TBL] [Abstract][Full Text] [Related]
54. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
Al-Raisi F; Mohsin N; Kamble P
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
[TBL] [Abstract][Full Text] [Related]
55. Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy.
Mainra R; Xu Q; Chibbar R; Hassan A; Shoker A
Transpl Immunol; 2013 Jun; 28(4):145-7. PubMed ID: 23685054
[TBL] [Abstract][Full Text] [Related]
56. Viral infections directly involved in kidney allograft function.
Masutani K
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():31-37. PubMed ID: 29968408
[TBL] [Abstract][Full Text] [Related]
57. Nephritic-nephrotic syndrome as a presentation of BK virus infection.
Derakhshan N; Derakhshan D; Torabinejad S; Derakhshan A
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):123-5. PubMed ID: 21196627
[TBL] [Abstract][Full Text] [Related]
58. Basiliximab for the therapy of acute T cell-mediated rejection in kidney transplant recipient with BK virus infection: A case report.
Chen T; Li X; Wang J; Wang X; Zhu T; Rong R; Yang C
Front Immunol; 2022; 13():1017872. PubMed ID: 36211389
[TBL] [Abstract][Full Text] [Related]
59. Prevalence and clinical course of BK virus nephropathy in pancreas after kidney transplant patients.
Duclos AJ; Krishnamurthi V; Lard M; Poggio E; Kleeman M; Winans C; Fatica R; Nurko S
Transplant Proc; 2006 Dec; 38(10):3666-72. PubMed ID: 17175362
[TBL] [Abstract][Full Text] [Related]
60. Polyomavirus-infected decoy cells in cytocentrifuged urine cytology specimens from renal transplant recipients.
Maia TM; Silva SF; Silva SL; Holanda MC; Nascimento JM; Ferreira MV
Acta Cytol; 2011; 55(5):445-8. PubMed ID: 21986172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
